87 related articles for article (PubMed ID: 22913641)
1. Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines.
Negri DR; Rossi A; Blasi M; Michelini Z; Leone P; Chiantore MV; Baroncelli S; Perretta G; Cimarelli A; Klotman ME; Cara A
Retrovirology; 2012 Aug; 9():69. PubMed ID: 22913641
[TBL] [Abstract][Full Text] [Related]
2. Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.
Ciré S; Da Rocha S; Yao R; Fisson S; Buchholz CJ; Collins MK; Galy A
PLoS One; 2014; 9(7):e101644. PubMed ID: 25058148
[TBL] [Abstract][Full Text] [Related]
3. Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro.
Norton TD; Miller EA; Bhardwaj N; Landau NR
Gene Ther; 2015 Mar; 22(3):227-36. PubMed ID: 25567537
[TBL] [Abstract][Full Text] [Related]
4. Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity.
Lin YY; Belle I; Blasi M; Huang MN; Buckley AF; Rountree W; Klotman ME; Cara A; Negri D
Mol Ther Methods Clin Dev; 2020 Jun; 17():532-544. PubMed ID: 32258216
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells.
Gómez-Moreno A; San Sebastian E; Moya J; Gomollón-Zueco P; Isola S; Vales Á; González-Aseguinolaza G; Unzu C; Garaigorta U
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896219
[TBL] [Abstract][Full Text] [Related]
6. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses.
Mahesh S; Li J; Travieso T; Psaradelli D; Negri D; Klotman M; Cara A; Blasi M
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005931
[TBL] [Abstract][Full Text] [Related]
7. HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65.
Fink DL; Cai J; Whelan MVX; Monit C; Maluquer de Motes C; Towers GJ; Sumner RP
Retrovirology; 2022 Jan; 19(1):2. PubMed ID: 35073912
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.
Bona R; Michelini Z; Mazzei C; Gallinaro A; Canitano A; Borghi M; Vescio MF; Di Virgilio A; Pirillo MF; Klotman ME; Negri D; Cara A
Mol Ther Methods Clin Dev; 2021 Dec; 23():263-275. PubMed ID: 34729374
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy Applications of Non-Human Lentiviral Vectors.
Munis AM
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003635
[TBL] [Abstract][Full Text] [Related]
10. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.
Luis A
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003492
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques.
Blasi M; Wescott EC; Baker EJ; Mildenberg B; LaBranche C; Rountree W; Haynes BF; Saunders KO; Moody MA; Negri D; Santra S; Cara A; Klotman ME
NPJ Vaccines; 2020; 5(1):36. PubMed ID: 32411399
[TBL] [Abstract][Full Text] [Related]
12. Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice.
Gallinaro A; Borghi M; Pirillo MF; Cecchetti S; Bona R; Canitano A; Michelini Z; Di Virgilio A; Olvera A; Brander C; Negri D; Cara A
Mol Ther Methods Clin Dev; 2020 Jun; 17():418-428. PubMed ID: 32154327
[TBL] [Abstract][Full Text] [Related]
13. The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes.
Sánchez-Hernández S; Gutierrez-Guerrero A; Martín-Guerra R; Cortijo-Gutierrez M; Tristán-Manzano M; Rodriguez-Perales S; Sanchez L; Garcia-Perez JL; Chato-Astrain J; Fernandez-Valades R; Carrillo-Galvez AB; Anderson P; Montes R; Real PJ; Martin F; Benabdellah K
Mol Ther Nucleic Acids; 2018 Dec; 13():16-28. PubMed ID: 30227274
[TBL] [Abstract][Full Text] [Related]
14. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.
Gallinaro A; Borghi M; Bona R; Grasso F; Calzoletti L; Palladino L; Cecchetti S; Vescio MF; Macchia D; Morante V; Canitano A; Temperton N; Castrucci MR; Salvatore M; Michelini Z; Cara A; Negri D
Front Immunol; 2018; 9():171. PubMed ID: 29459873
[TBL] [Abstract][Full Text] [Related]
15. Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
Pay SL; Qi X; Willard JF; Godoy J; Sankhavaram K; Horton R; Mitter SK; Quigley JL; Chang LJ; Grant MB; Boulton ME
Hum Gene Ther Methods; 2018 Feb; 29(1):44-59. PubMed ID: 29160102
[TBL] [Abstract][Full Text] [Related]
16. Design and Potential of Non-Integrating Lentiviral Vectors.
Shaw A; Cornetta K
Biomedicines; 2014 Jan; 2(1):14-35. PubMed ID: 28548058
[TBL] [Abstract][Full Text] [Related]
17. Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.
Negri D; Blasi M; LaBranche C; Parks R; Balachandran H; Lifton M; Shen X; Denny T; Ferrari G; Vescio MF; Andersen H; Montefiori DC; Tomaras GD; Liao HX; Santra S; Haynes BF; Klotman ME; Cara A
Mol Ther; 2016 Nov; 24(11):2021-2032. PubMed ID: 27455880
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Lentiviral Vaccines for HIV-1 Infection.
Norton TD; Miller EA
Front Immunol; 2016; 7():243. PubMed ID: 27446074
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
